Accelerating antimicrobial stewardship: An AI-CDSS approach to combating multidrug-resistant pathogens in the era of increasing resistance.
Journal:
Clinica chimica acta; international journal of clinical chemistry
Published Date:
Apr 29, 2025
Abstract
OBJECTIVES: The World Health Organization has identified Klebsiella pneumoniae (KP) and Pseudomonas aeruginosa (PA) as significant public health threats owing to high antibiotic resistance. Traditional antibiotic susceptibility testing (AST) methods, crucial for determining the most suitable treatment regimen, typically require approximately 48-96 h (2-4 days) to yield results, including bacterial culture, rapid identification via matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS), and subsequent AST, which is too long for urgent clinical decisions. Here, we developed an artificial intelligence-clinical decision support system (AI-CDSS) utilizing machine learning to analyze MALDI-TOF MS data for antibiotic resistance prediction for these pathogens.
Authors
Keywords
Anti-Bacterial Agents
Antimicrobial Stewardship
Artificial Intelligence
Decision Support Systems, Clinical
Drug Resistance, Multiple, Bacterial
Humans
Klebsiella pneumoniae
Machine Learning
Microbial Sensitivity Tests
Pseudomonas aeruginosa
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization